BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson M. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231 [PMID: 32476788 DOI: 10.3748/wjg.v26.i18.2221] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Tian J, Meng B, Wang K, Zheng C, Liu Y, Yan J, Han Q, Zhang Y. Application of Extreme Learning Machine in the Survival Analysis of Chronic Heart Failure Patients With High Percentage of Censored Survival Time. Front Cardiovasc Med 2021;8:726516. [PMID: 34778396 DOI: 10.3389/fcvm.2021.726516] [Reference Citation Analysis]
2 Sohal A, Green V, Sandhu S, Roytman M. Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management. J Community Hosp Intern Med Perspect 2021;11:722-6. [PMID: 34567473 DOI: 10.1080/20009666.2021.1954784] [Reference Citation Analysis]
3 Rahimi RS, Brown KA, Flamm SL, Brown RS Jr,. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes. Am J Med 2021:S0002-9343(21)00409-5. [PMID: 34242619 DOI: 10.1016/j.amjmed.2021.06.007] [Reference Citation Analysis]
4 Brusilow WSA. Saul Brusilow: Understanding and treating diseases of ammonia toxicity. Anal Biochem 2022;636:114478. [PMID: 34808107 DOI: 10.1016/j.ab.2021.114478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang CH, Tseng HJ, Amodio P, Chen YL, Wang SF, Chang SH, Hsieh SY, Lin CY. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELD. J Pers Med 2020;10:E186. [PMID: 33105871 DOI: 10.3390/jpm10040186] [Reference Citation Analysis]
6 Tian Y, Yang W, Yang R, Zhang Q, Hao L, Bian E, Yang Y, Huang X, Wu Y, Zhang B. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5. Toxicol Appl Pharmacol 2021;435:115829. [PMID: 34919946 DOI: 10.1016/j.taap.2021.115829] [Reference Citation Analysis]
7 Elzubeir A, Alam SM. Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’. World J Gastroenterol 2020; 26(44): 7085-7087 [PMID: 33311952 DOI: 10.3748/wjg.v26.i44.7085] [Reference Citation Analysis]
8 Tan J, He Y, Li Z, Zhang Q, Yang Y, Xu Q, Xu X. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions. Front Public Health 2022;10:919549. [DOI: 10.3389/fpubh.2022.919549] [Reference Citation Analysis]